My thoughts for the Wednesday meeting: I am hoping for more clear deliverable timeframes and decisions on EUA USA, NASDAQ...on the EUA for the UK since they listed in the agenda details on detailed conversations with MSRA I am intrigued on how that one is progressing. The response to the FDA regarding HIV I am sure Cytodyn will meet their 9/4 date so that’s in the bank. The cancer updates I am very interested in since it’s one of the main reasons I bought the stock. So if any deliverable is actually announced in the meeting I see that as upside but I’m not counting on that..